# Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

> **NCT01943058** · PHASE2 · WITHDRAWN · sponsor: **University of Southern California**

## Conditions studied

- Atypical Endometrial Hyperplasia
- Endometrial Adenocarcinoma
- Recurrent Endometrial Carcinoma
- Stage IA Endometrial Carcinoma
- Stage IB Endometrial Carcinoma
- Stage II Endometrial Carcinoma
- Stage IIIA Endometrial Carcinoma
- Stage IIIB Endometrial Carcinoma
- Stage IIIC Endometrial Carcinoma
- Stage IVA Endometrial Carcinoma
- Stage IVB Endometrial Carcinoma

## Interventions

- **DRUG:** megestrol acetate
- **DEVICE:** levonorgestrel-releasing intrauterine system
- **OTHER:** laboratory biomarker analysis
- **OTHER:** questionnaire administration

## Key facts

- **NCT ID:** NCT01943058
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-03
- **Primary completion:** 2016-10
- **Final completion:** 2017-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2014-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01943058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01943058, "Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01943058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*